Who
Jason A. Okazaki
CEO and President
Company insider
Files Form 4 as: CEO and President, Assembly Biosciences.
In numbers
- Trades disclosed
- 34
- Buys
- 0
- Sells
- 14
- Bought
- $0
- Sold
- $101K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 26 Mar 2020
- Last trade
- 29 Mar 2026
- Last filed
- 5 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Mar 2026filed 5 Jun 2026 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —50,750 at $0.00 | filing |
| 29 Mar 2026filed 5 Jun 2026 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —50,750 at $0.00 | filing |
| 29 Mar 2026filed 31 Mar 2026 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —94,250 at $0.00 | filing |
| 29 Mar 2026filed 31 Mar 2026 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —94,250 at $0.00 | filing |
| 31 Mar 2025filed 1 Apr 2025 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $3,497355 at $9.85 | filing |
| 29 Mar 2025filed 1 Apr 2025 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —71,100 at $0.00 | filing |
| 3 Oct 2024filed 4 Oct 2024 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $2,918197 at $14.81 | filing |
| 2 Aug 2024filed 5 Aug 2024 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $14K981 at $14.23 | filing |
| 23 May 2024filed 24 May 2024 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $8,197549 at $14.93 | filing |
| 30 Apr 2024filed 1 May 2024 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $20K1,569 at $12.71 | filing |
| 29 Apr 2024filed 1 May 2024 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —4,166 at $0.00 | filing |
| 1 Apr 2024filed 2 Apr 2024 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $4,627354 at $13.07 | filing |
| 29 Mar 2024filed 2 Apr 2024 | ASMB Assembly Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,000 at $0.00 | filing |
| 27 Mar 2024filed 29 Mar 2024 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $5,045392 at $12.87 | filing |
| 3 Oct 2023filed 4 Oct 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $1,8902,363 at $0.80 | filing |
| 2 Oct 2023filed 4 Oct 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 2 Aug 2023filed 3 Aug 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $13K11,827 at $1.09 | filing |
| 22 Jun 2023filed 23 Jun 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —50,000 at $0.00 | filing |
| 23 May 2023filed 24 May 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Sold | $6,8236,561 at $1.04 | filing |
| 22 May 2023filed 24 May 2023 | ASMB Assembly BiosciencesBiotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.